Illustrative image – not actual.Arvind Remedies, a Chennai based pharma company, has
plans to set up a manufacturing facility near Chennai. The facility would
confirm to the US FDA and UK MCA standards and would manufacture tablets,
injectables and soft gelatin capsules.
The facility is estimated to cost Rs.50 crore, which
would be brought in through term loans and internal accruals. The facility is
expected to begin operations by 2003.
The company, which is already present in paediatrics,
pain management, gynaecology and diabetes segment, plans to look at endocrinology,
dermatology, cardiovascular diseases and nutrition as the new focus areas and
intends to launch new products over the next year.
According to reports, Arvind Remedies currently earns
70 per cent of its total revenues from allopathic medicines, while the balance
comes from ayurvedic medicines.
